Assessments

This webpage provides access to Sentinel assessments that have been conducted by U.S. FDA’s Center for Drug Evaluation and Research (CDER).  The search options below can be used to find materials based on medical product, safety outcome, and the following study types:

  • Exploratory Analyses characterize the rates of health outcomes, examine medical product use, and explore the feasibility of more detailed evaluations. 
  • Safety Analyses build on exploratory work and formally evaluate medical product-outcome associations using more advanced study designs and statistical methods to control for confounding. 

Search results provide a listing of assessments, reported results, related links to publications, and FDA Drug Safety Communications. If you wish to search for information on other types of projects, a comprehensive listing of all Sentinel projects, including all assessments, data, surveillance tools, methods, and communication materials can be accessed using the Report Finder.

Disclaimer
The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from Sentinel in the public domain as soon as possible. Please read the disclaimer.

Most Recent Drug Assessments

TitleDate Posted
Sentinel Modular Program Report: Actemra (Tocilizumab) Use Among Pregnant Women07/18/2017
Sentinel Modular Program Report: Glyburide vs Glipizide and Hypoglycemia, Report 107/18/2017
Sentinel Modular Program Report: Glyburide vs Glipizide and Hypoglycemia, Report 207/18/2017
Sentinel Modular Program Report: Glyburide vs Glipizide and Hypoglycemia, Report 307/18/2017
Sentinel Modular Program Report: Glyburide vs Glipizide and Hypoglycemia, Report 407/18/2017
Mini-Sentinel Modular Program Report: AEDs and Angioedema07/17/2017
Sentinel Summary Table Report: 2015 NMEs Incident Use05/11/2017
Sentinel Summary Table Report: 2015 NMEs Prevalent Use05/11/2017
Sentinel Summary Table Report: 2015 NMEs HCPCS05/11/2017
Sentinel Modular Program Report: Multiple Births and Preterm Delivery05/10/2017
Sentinel Modular Program Report: Combined Pharmacogenetic Testing05/10/2017
Sentinel Modular Program Report: Influenza Antiviral Drug Use 2010-201505/04/2017
Sentinel Summary Table Report: Influenza Antiviral Drug Use 2010-2015 Prevalent05/04/2017
Sentinel Summary Table Report: Influenza Antiviral Drug Use 2010-2015 Incident05/04/2017
Sentinel Summary Table Report: 2011 NMEs Incident Use04/24/2017
Sentinel Summary Table Report: 2011 NMEs Prevalent Use04/24/2017
Sentinel Summary Table Report: 2011 NMEs HCPCS04/24/2017
Sentinel Summary Table Report: 2012 NMEs Incident Use04/24/2017
Sentinel Summary Table Report: 2012 NMEs Prevalent Use04/24/2017
Sentinel Summary Table Report: 2012 NMEs HCPCS04/24/2017
Sentinel Summary Table Report: Brintellix/Brilinta04/24/2017
Sentinel Summary Table Report: 2013 NMEs Incident Use03/21/2017
Sentinel Summary Table Report: 2013 NMEs Prevalent Use03/21/2017
Sentinel Summary Table Report: 2014 NMEs Incident Use03/21/2017
Sentinel Summary Table Report: 2014 NMEs Prevalent Use03/21/2017
Sentinel Summary Table Report: 2013 NMEs HCPCS03/21/2017
Sentinel Summary Table Report: 2014 NMEs HCPCS03/21/2017